...
首页> 外文期刊>Bioorganic and Medicinal Chemistry Letters >Submonomer synthesis of azapeptide ligands of the Insulin Receptor Tyrosine Kinase domain
【24h】

Submonomer synthesis of azapeptide ligands of the Insulin Receptor Tyrosine Kinase domain

机译:胰岛素受体酪氨酸激酶结构域的氮杂肽配体的亚单体合成

获取原文
获取原文并翻译 | 示例
           

摘要

Azapeptide ligands of the Insulin Receptor Tyrosine Kinase (IRTK) were developed by solid-phase submonomer azapeptide synthesis in sufficient isolated yields (36-55%) and purities 95% for structure-activity relationship studies. The azapeptides adopted folded geometries with some proportion of random coil according to CD and NMR spectroscopy. In vitro phosphorylation of the IRTK domain in the presence of azapeptides produced a lead inhibitor, Ac-DIazaYET-NH2 (~50% at 400 μM) whereas the [aza-DOPA 3] and [aza-Glu4] analogs were found to stimulate IRTK phosphorylations. Thus, azapeptide ligands of the IRTK provide important modulatory activity of this important class of enzymes for anti-cancer and related applications in drug discovery.
机译:胰岛素受体酪氨酸激酶(IRTK)的氮杂肽配体是通过固相亚单体氮杂肽合成而开发的,具有足够的分离收率(36-55%),纯度> 95%,用于结构-活性关系研究。根据CD和NMR光谱,氮杂肽采用折叠的几何形状并具有一定比例的无规卷曲。在存在氮杂肽的情况下,IRTK结构域的体外磷酸化产生了铅抑制剂Ac-DIazaYET-NH2(在400μM时约为50%),而发现[aza-DOPA 3]和[aza-Glu4]类似物可以刺激IRTK。磷酸化。因此,IRTK的氮杂肽配体为药物开发中的抗癌和相关应用提供了这一重要酶类的重要调节活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号